(BRT) BRT Realty Trust - Ratings and Ratios
Multi-Family Properties, Joint Ventures, Preferred Equity
Dividends
| Dividend Yield | 6.90% |
| Yield on Cost 5y | 8.84% |
| Yield CAGR 5y | 3.25% |
| Payout Consistency | 49.5% |
| Payout Ratio | 500.0% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 27.1% |
| Value at Risk 5%th | 42.4% |
| Relative Tail Risk | -4.81% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.94 |
| Alpha | -30.52 |
| CAGR/Max DD | -0.20 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.423 |
| Beta | 0.522 |
| Beta Downside | 0.468 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.11% |
| Mean DD | 13.73% |
| Median DD | 13.97% |
Description: BRT BRT Realty Trust October 27, 2025
BRT Apartments Corp. (NYSE:BRT) is a Maryland-based REIT that owns, operates and modestly develops multi-family housing. As of June 30 2025 the portfolio comprises 29 properties in 11 states-21 wholly-owned assets (5,420 units) valued at $605.3 million, plus equity stakes in eight joint-venture properties (2,527 units) worth $30.0 million, and two JV properties accounted for as preferred-equity loans ($17.7 million). The remaining $1.8 million reflects other consolidated and unconsolidated holdings. The company’s footprint is concentrated in the Southeast and Texas, positioning it to benefit from strong population inflows and job growth in those regions.
Key sector metrics that shape BRT’s outlook include: (1) national multi-family occupancy averaging ~95% in Q3 2025, which supports stable cash flow; (2) average rent growth of roughly 4.2% YoY, outpacing inflation and indicating pricing power; and (3) a REIT-wide weighted average cap rate of about 5.8% for comparable assets, suggesting modest valuation upside if interest rates stabilize. Additionally, BRT’s leverage ratio of 45% debt-to-FFO aligns with industry norms, giving it flexibility to pursue opportunistic acquisitions as the supply pipeline eases.
If you’re looking to deepen the analysis, a quick review of BRT’s recent Form 10-K and the ValueRay platform can surface granular performance drivers and peer comparisons that may inform a more data-driven investment thesis.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (-9.70m TTM) > 0 and > 6% of Revenue (6% = 5.77m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 0.56pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 10.18% (prev 23.36%; Δ -13.18pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 25.4m > Net Income -9.70m (YES >=105%, WARN >=100%) |
| Net Debt (-21.1m) to EBITDA (40.0m) ratio: -0.53 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.34 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (18.0m) change vs 12m ago 1.31% (target <= -2.0% for YES) |
| Gross Margin 54.29% (prev 54.76%; Δ -0.47pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 13.43% (prev 13.20%; Δ 0.23pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.59 (EBITDA TTM 40.0m / Interest Expense TTM 23.1m) >= 6 (WARN >= 3) |
Altman Z'' -0.37
| (A) 0.01 = (Total Current Assets 38.8m - Total Current Liabilities 29.0m) / Total Assets 714.2m |
| (B) -0.13 = Retained Earnings (Balance) -89.3m / Total Assets 714.2m |
| (C) 0.02 = EBIT TTM 13.7m / Avg Total Assets 716.0m |
| (D) -0.17 = Book Value of Equity -89.1m / Total Liabilities 527.5m |
| Total Rating: -0.37 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 59.57
| 1. Piotroski 4.0pt |
| 2. FCF Yield 3.40% |
| 3. FCF Margin 26.04% |
| 4. Debt/Equity 2.59 |
| 5. Debt/Ebitda -0.53 |
| 6. ROIC - WACC (= -1.63)% |
| 7. RoE -4.96% |
| 8. Rev. Trend 72.58% |
| 9. EPS Trend -51.51% |
What is the price of BRT shares?
Over the past week, the price has changed by -2.69%, over one month by -1.02%, over three months by -6.57% and over the past year by -16.77%.
Is BRT a buy, sell or hold?
- Strong Buy: 1
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BRT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 18.5 | 27.7% |
| Analysts Target Price | 18.5 | 27.7% |
| ValueRay Target Price | 15.1 | 4.3% |
BRT Fundamental Data Overview November 24, 2025
P/S = 2.787
P/B = 1.4626
Beta = 0.982
Revenue TTM = 96.2m USD
EBIT TTM = 13.7m USD
EBITDA TTM = 40.0m USD
Long Term Debt = 498.5m USD (from longTermDebt, last quarter)
Short Term Debt = 17.0m USD (from shortTermDebt, last fiscal year)
Debt = 483.6m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -21.1m USD (from netDebt column, last quarter)
Enterprise Value = 735.7m USD (273.1m + Debt 483.6m - CCE 21.1m)
Interest Coverage Ratio = 0.59 (Ebit TTM 13.7m / Interest Expense TTM 23.1m)
FCF Yield = 3.40% (FCF TTM 25.0m / Enterprise Value 735.7m)
FCF Margin = 26.04% (FCF TTM 25.0m / Revenue TTM 96.2m)
Net Margin = -10.08% (Net Income TTM -9.70m / Revenue TTM 96.2m)
Gross Margin = 54.29% ((Revenue TTM 96.2m - Cost of Revenue TTM 44.0m) / Revenue TTM)
Gross Margin QoQ = 53.58% (prev 53.15%)
Tobins Q-Ratio = 1.03 (Enterprise Value 735.7m / Total Assets 714.2m)
Interest Expense / Debt = 1.22% (Interest Expense 5.88m / Debt 483.6m)
Taxrate = -0.07% (negative due to tax credits) (2000 / -2.71m)
NOPAT = 13.7m (EBIT 13.7m * (1 - -0.07%)) [negative tax rate / tax credits]
Current Ratio = 1.34 (Total Current Assets 38.8m / Total Current Liabilities 29.0m)
Debt / Equity = 2.59 (Debt 483.6m / totalStockholderEquity, last quarter 186.7m)
Debt / EBITDA = -0.53 (Net Debt -21.1m / EBITDA 40.0m)
Debt / FCF = -0.84 (Net Debt -21.1m / FCF TTM 25.0m)
Total Stockholder Equity = 195.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.36% (Net Income -9.70m / Total Assets 714.2m)
RoE = -4.96% (Net Income TTM -9.70m / Total Stockholder Equity 195.6m)
RoCE = 1.98% (EBIT 13.7m / Capital Employed (Equity 195.6m + L.T.Debt 498.5m))
RoIC = 2.01% (NOPAT 13.7m / Invested Capital 682.4m)
WACC = 3.64% (E(273.1m)/V(756.8m) * Re(7.94%) + D(483.6m)/V(756.8m) * Rd(1.22%) * (1-Tc(-0.00)))
Discount Rate = 7.94% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 1.19%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈23.5m ; Y1≈29.0m ; Y5≈49.4m
Fair Price DCF = 44.18 (DCF Value 840.3m / Shares Outstanding 19.0m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -51.51 | EPS CAGR: -11.44% | SUE: 0.0 | # QB: 0
Revenue Correlation: 72.58 | Revenue CAGR: 25.96% | SUE: 1.91 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-0.13 | Chg30d=-0.005 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.58 | Chg30d=-0.060 | Revisions Net=+1 | Growth EPS=-1.8% | Growth Revenue=+3.1%
Additional Sources for BRT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle